Mario Di Matteo
- Immunology top 5%
- Immune cells in cancer 3
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 3
- Oncology top 5%
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 4
- Glycosylation and Glycoproteins Research 3
- CRISPR and Genetic Engineering 3
- Pluripotent Stem Cells Research 2
- Hepatology top 10%
-
- Virus-based gene therapy research 4
-
- Cancer Research and Treatments 2
- Co-authors
- Massimiliano MazzoneHans PrenenJens SerneelsMin ShangPeter CarmelietBart GhesquièreRosa Martín‐PérezMathias Wenes
- Cited by
- ImmunologyCancer ResearchOncology
- Partner nations
- BelgiumItalyUnited Kingdom
In The Last Decade
Mario Di Matteo
20 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Immunology 745
- Cancer Research 335
- Oncology 481
- Molecular Biology 803
- Hepatology 69
Countries citing papers authored by Mario Di Matteo
This map shows the geographic impact of Mario Di Matteo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Di Matteo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Di Matteo more than expected).
Fields of papers citing papers by Mario Di Matteo
This network shows the impact of papers produced by Mario Di Matteo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Di Matteo. The network helps show where Mario Di Matteo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mario Di Matteo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 18 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 29 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 178 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 20 | |
| 9 | 2019 | 174 | |
| 10 | 2019 | 2 | |
| 11 | 2017 | 95 | |
| 12 | 2016 | 388 | |
| 13 | MET is required for the recruitment of anti-tumoural neutrophilsbreakdown → | 2015 | 378 |
| 14 | 2015 | 18 | |
| 15 | 2015 | 65 | |
| 16 | 2014 | 39 | |
| 17 | 2012 | 42 | |
| 18 | 2012 | 36 | |
| 19 | 2012 | 73 | |
| 20 | 2009 | 14 |
About Mario Di Matteo
Mario Di Matteo is a scholar working on Immunology, Cancer Research and Biotechnology, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), RNA Interference and Gene Delivery (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), CRISPR and Genetic Engineering (3 papers), Immune cells in cancer (3 papers), Pluripotent Stem Cells Research (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Immunology (745 citations), Cancer Research (335 citations) and Oncology (481 citations). Mario Di Matteo has collaborated with scholars based in Belgium, Italy and United Kingdom. Frequent co-authors include Massimiliano Mazzone, Hans Prenen, Jens Serneels, Min Shang, Peter Carmeliet, Bart Ghesquière, Rosa Martín‐Pérez, Mathias Wenes, Jermaine Goveia and Giusy Di Conza. Their work appears in journals such as Cell Metabolism, Nature, Cancer Immunology Research, Molecular Therapy and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.